STI

Nurx collects another $22.5M for birth control & STI treatment deliveries
By Dave Muoio | 03:37 pm | August 11, 2020
Noting a spike in demand due to COVID-19, the company predicts that it will reach profitability by early 2021. 
Nurx adds STI testing to its mail-order product suite
By Laura Lovett | 04:51 pm | July 10, 2019
The startup launched three new test kits, which will test for conditions such as chlamydia, gonorrhea and syphilis.